These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11028309)

  • 1. [Losartan potassium, an angiotensin II receptor antagonist].
    Yoshinaga K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():140-3. PubMed ID: 11028309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension in patients with cardiac hypertrophy].
    Kohno M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
    [No Abstract]   [Full Text] [Related]  

  • 3. Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.
    McIntyre M; Caffe SE; Michalak RA; Reid JL
    Pharmacol Ther; 1997; 74(2):181-94. PubMed ID: 9336021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin II receptor antagonists: a review of the development and future perspective].
    Saito I; Saruta T
    Nihon Rinsho; 1999 May; 57(5):1015-9. PubMed ID: 10361427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
    Chiu AG; Krowiak EJ; Deeb ZE
    Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of losartan, an angiotensin II receptor antagonist, on the fibrinolytic system in hypertensive patients.
    Saito M; Kawasaki S; Hashiba T; Chen CJ; Hatakeyama H; Asakura H; Kikuchi M; Matsuda T
    Int J Hematol; 1999 Jul; 70(1):60-1. PubMed ID: 10446499
    [No Abstract]   [Full Text] [Related]  

  • 8. [The usefulness of a new class antihypertensive drug, angiotensin II receptor antagonist, for essential hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1999 May; 57(5):1141-7. PubMed ID: 10361448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Losartan, new angiotensin receptor antagonist--a challenge for enzyme converting angiotensin inhibitors?].
    Chabielska E; Pawlak R
    Wiad Lek; 1995; 48(1-12):242-5. PubMed ID: 9638249
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of efficacy and safety of losartan (losar) in Asian Indian hypertensives.
    Joshi SR; Kale S; Oomman A; Joshi RM; Chopra D
    J Indian Med Assoc; 2005 Jul; 103(7):392, 394-6. PubMed ID: 16366194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current therapy: losartan].
    Degaute JP; Sternon J
    Rev Med Brux; 1997 Oct; 18(5):335-8. PubMed ID: 9441330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan and renal transplantation.
    Horn S; Holzer H; Horina J
    Lancet; 1998 Jan; 351(9096):111. PubMed ID: 9439500
    [No Abstract]   [Full Text] [Related]  

  • 15. [AT1 receptor antagonist lorsartan and organ protection. Managing hypertension a different way].
    MMW Fortschr Med; 2006 Mar; 148(13):48-9. PubMed ID: 16642707
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists: what future?
    Onuigbo M
    South Med J; 1998 Aug; 91(8):794-6. PubMed ID: 9715233
    [No Abstract]   [Full Text] [Related]  

  • 17. Losartan potassium (Cozaar).
    Lindenfeld J; Borer J; Armstrong PW
    Circulation; 2002 Apr; 105(16):e9100. PubMed ID: 11997294
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
    Neki NS; Arora P
    J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan and hypertensive children. Another option for a small number of children.
    Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20939445
    [No Abstract]   [Full Text] [Related]  

  • 20. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.